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Yoriko Saito2, Akiko Kaneko2, Kanako Shimizu3, Daisuke Yamada1, Narumi Ogonuki5, Takashi Watanabe4,
Manabu Nakayama6, Yoko Koseki1, Fuyuko Kezuka-Shiotani1, Takanori Hasegawa1, Hiromasa Yabe7, Shunichi Kato7,
Atsuo Ogura5, Leonard D Shultz8, Osamu Ohara4,6 , Masaru Taniguchi9, Haruhiko Koseki1 , Shin-ichiro Fujii3,
Fumihiko Ishikawa2
The immune system encompasses acquired and innate immunity
that matures through interaction with microenvironmental
components. Cytokines serve as environmental factors that
foster functional maturation of immune cells. Although NOD/
SCID/IL2rgKO (NSG) humanized mice support investigation of
human immunity in vivo, a species barrier between human im-
mune cells and the mouse microenvironment limits human ac-
quired as well as innate immune function. To study the roles of
human cytokines in human acquired and innate immune cell
development, we created NSG mice expressing hIL-7 and hIL-15.
Although hIL-7 alone was not sufficient for supporting human NK
cell development in vivo, increased frequencies of humanNK cells
were confirmed in multiple organs of hIL-7 and hIL-15 double
knockin (hIL-7xhIL-15 KI) NSG mice engrafted with human he-
matopoietic stem cells. hIL-7xhIL-15 KI NSG humanized mice
provide a valuable in vivo model to investigate development and
function of human NK cells.
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Introduction
Cytokine receptor signaling is indispensable for reconstitution of
the human immune system following hematopoietic stem cell
(HSC) therapy. Among multiple cytokines, IL-7 promotes differ-
entiation and maturation of T cells, B cells (Mackall et al, 2011),
and innate lymphoid cells (Moro et al, 2010). In addition to the
development of mature lymphoid cells, IL-7 signaling plays a
pivotal role at the level of progenitor cells. Studies of IL-7– or
IL-7R–deficient mice revealed multiple defects in T- and B-cell
development (Peschon et al, 1994; von Freeden-Jeffry et al, 1995).
Defective IL-7R expression in humans results in T−B+NK+ SCID (Puel
et al, 1998).
IL-15 supports innate lymphoid cell development (Ali et al,
2015). Studies using IL-15 transgenic mice (Fehniger et al, 2001)
and IL-15 knockout (IL-15KO) mice (Kennedy et al, 2000) have
shown IL-15 to be essential in the development of NK cells, natural
killer T (NKT) cells, and memory CD8+ T cells. Knocking out the
genes encoding IL-15 or IL-15Rα results in complete loss of NK
cells in the thymus, BM, and spleen. NKT cells and CD44high
memory phenotype CD8+ T cells were also reduced in IL-15KO and
IL-15Rα knockout mice (Lodolce et al, 1998; Kennedy et al, 2000). A
recent report demonstrated a role of IL-15 in anticancer immunity
in that the frequencies of breast cancer metastasis were more
frequent in IL-15KO mice than those in IL-15 transgenic mice or in
C57BL/6 control mice (Gillgrass et al, 2014).
We developed NOD/SCID/IL2rgKO (NSG) mice to investigate the
in vivo dynamics of the human immune system (Ishikawa et al, 2005;
Shultz et al, 2005). In studies of humanized mice engrafted with
humanHSC, we and others reported development of human T and B
cells. However, the frequencies of human NK cells did not reach
physiological levels in NSG humanized mice (Andre et al, 2010). The
decreased NK cell development could be due to the species barrier
between human lymphoid or NK cell progenitors and recipient
microenvironment (Mestas & Hughes, 2004).
To investigate the in vivo function of human IL-7 and IL-15 in the
development of the human immune system, we created new strains
of NSG mice expressing either hIL-7 alone (hIL-7TG NSG mice and
hIL-7 KI NSG mice) and mice expressing hIL-7 and hIL-15 (hIL-7xhIL-
15 KI NSG mice). Analyses of these mice engrafted with human HSCs
showed that hIL-15 is required for NK cell development. In addition,
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we found multiple subsets of human T cells in NSG recipient mice
expressing human IL-7 and IL-15, demonstrating the roles of these
cytokines in human T-cell development. These new humanized
mouse models may support studies of human monoclonal anti-
body therapy in vivo and for studies of human acquired and innate
tumor immunity.
Results
Reconstitution of human immunity in the presence of hIL-7
To study potential roles of human IL-7 in lymphoid cell devel-
opment, we created hIL-7 KI and hIL-7 TG NSG mice. We first looked
at effects of transgenic expression of human IL-7. When we
compared reconstitution of T cells, B cells, and NK cells in the BM
and spleen of cord blood (CB) HSC-engrafted NSG mice with or
without expression of hIL-7, we did not find significant differences
in the frequencies of each lineage within hCD45+ cells (NSG, n = 21:
BM T cells 37.7 ± 5.7%, BM B cells 35.4 ± 3.8%, BM NK cells 1.0 ± 0.2%,
spleen T cells 48.1 ± 4.8%, spleen B cells 44.6 ± 4.3%, spleen NK cells
0.7 ± 0.1%; hIL-7 TG NSG, n = 3: BM T cells 28.7 ± 27.1%, BM B cells
42.0 ± 18.9%, BM NK cells 0.8 ± 0.2%, spleen T cells 38.5 ± 23.5%,
spleen B cells 47.9 ± 18.8%, spleen NK cells 0.7 ± 0.3%; hIL-7 KI NSG,
n = 4: BM T cells 11.4 ± 5.9%, BM B cells 29.8 ± 8.9%, BM NK cells 1.2 ±
0.5%, spleen T cells 53.4 ± 11.3%, spleen B cells 30.9 ± 8.0%, spleen
NK cells 2.6 ± 1.0%; representative flow cytometry plots shown in
Fig S1A and summarized data shown in Table S1). Because IL-7 has
been reported to promote B-cell differentiation and maturation,
we next evaluated human B-cell subsets in hIL-7 KI NSG hu-
manized mice. In the BM, the majority of human CD19+ cells were
CD10+CD20− pro-B cells, while IgM+IgDlow transitional and IgM+IgD+
or IgMlowIgD+ mature B cells accounted for more than 70% of
human B cells in the spleen (representative flow cytometry plots
shown in Fig S1B). The frequencies of human B-cell subsets were
not altered significantly in hIL-7 KI NSG humanized mice (NSG, n = 4:
BM CD10+CD20− cells 84.4 ± 3.9%, BM IgM+ cells 23.7 ± 2.6%, spleen
CD10+CD20− cells 31.3 ± 6.3%, spleen IgM+ cells 71.0 ± 5.4%; hIL-7 KI,
n = 3: BM CD10+CD20− cells 81.9 ± 1.9%, BM IgM+ cells 23.3 ± 5.9%,
spleen CD10+CD20− cells 21.0 ± 5.4%, spleen IgM+ cells 73.4 ± 2.1%;
summarized data shown in Table S2).
Reconstitution of human immunity in the presence of hIL-7 and
hIL-15
To examine the role of hIL-15 and hIL-7 in human immune cell
development, a new strain of NSGmice expressing hIL-15 and both
hIL-7 and hIL-15 (hIL-7xhIL-15 KI NSG) were created. Plasma
concentrations of human IL-7 and human IL-15 in hIL-7xhIL-15 KI
NSG mice (n = 8) were 1.9 ± 0.3 pg/ml and 87.8 ± 9.8 pg/ml, re-
spectively (Fig S2). We then reconstituted human immunity by
intravenously injecting 2.5 × 103 to 2.6 × 104 CB CD34+CD38−CD45RA−
or CD34+CD38−CD90+CD45RA− HSCs into NSG or hIL-7xhIL-15 KI NSG
newborns (Table 1). In the recipient BM, thymus, spleen, and
peripheral blood (PB), we found significantly higher frequencies
of human CD56+ NK cells in hIL-7xhIL-15 KI NSG humanized mice
compared with conventional NSG humanized mice (NSG, n = 21: BM
NK cells 1.0 ± 0.2%, spleen NK cells 0.7 ± 0.1%, PB NK cells 1.0 ± 0.2%;
hIL-7xhIL-15 KI NSG, n = 17: BM NK cells 17.7 ± 4.7%, spleen NK cells
28.3 ± 5.3%, PB NK cells 43.1 ± 5.4%; NSG, n = 18: thymus NK cells 0.8 ±
0.2%; and hIL-7xhIL-15 KI NSG, n = 13: thymus NK cells 7.2 ± 1.4%. P <
0.001 in BM, spleen, PB, and thymus, by two-tailed t test; Fig 1A–C,
absolute numbers of cells are shown in Table S3). We confirmed
efficient differentiation of human CD56+ NK cells in the BM, spleen,
and PB of hIL-15 KI NSG humanized mice (representative flow
cytometry plots shown in Fig S3 and summarized data shown in
Table S4); therefore, we expected the presence of both hIL-7 and
hIL-15 to further enhance development of human innate lymphoid
cells.
hIL-15 has been reported to be secreted from myeloid cells (Cui
et al, 2014) by trans-presentation (Stonier & Schluns, 2010). Con-
sistent with this, we confirmed expression of human IL-15 in Gra1+
Mac1+ mouse myeloid cells of hIL-7xhIL-15 KI NSG humanized mice,
not in CD45+CD33+ human myeloid cells or Gra1+Mac1+ mouse
myeloid cells purified from conventional NSG humanizedmice (NSG
n = 3 and IL7xIL15 n = 3; Fig 1D). In addition, we detected tissue-
resident NK cells such as CXCR6+ NK cells (Stegmann et al, 2016) in
BM and liver of hIL-7xhIL-15 KI NSG humanized mice (BM n = 8, Liver
n = 5, PB n = 4: BM CXCR6+CD56+NK cells 67.6 ± 2.3%, liver CXCR6+CD56+
NK cells 10.2 ± 5.1%, PB CXCR6+CD56+NK cells 1.4 ± 0.9%; Fig 1E and F).
In addition to human NK cell development, we examined
whether the cytokines facilitate the development of human T cells
or induce skewing of specific human T-cell subsets. To this end, we
first analyzed development of human T-cell subsets in the thymus
and spleen. Within the thymic hCD45+CD56−CD3+ fraction, we found
higher frequency of CD4−CD8+ single positive T cells in hIL-7xhIL-15
KI NSG humanized mice (NSG, n = 18: CD4−CD8+ cells 15.6 ± 3.1%;
hIL7xhIL-15 KI NSG, n = 12: CD4−CD8+ cells 59.5 ± 5.9%. P < 0.001 by
two-tailed t test; Fig 2A and B, absolute numbers of cells are shown
in Table S3).
Next, using spleen cells, we examined the frequencies of human
CD3+ T, CD4+ T, and CD8+ T cells and their CD45RA and Foxp3 ex-
pression in NSG and hIL-7xhIL-15 KI NSG humanized mice (repre-
sentative flow cytometry plots shown in Fig 2C). We found that both
CD45RA+ naive and CD45RA− memory T cells were present in CD4+ T
or CD8+ T-cell populations of hIL-7xhIL-15 KI NSG humanized mice
(NSG, n = 7: CD4+CD45RA+ cells 3.3 ± 1.0%, CD4+CD45RA− cells 96.7 ±
1.0%, CD8+CD45RA+ cells 30.6 ± 6.6%, CD8+CD45RA− cells 69.5 ± 6.6%;
hIL-7xhIL-15 KI NSG, n = 5: CD4+CD45RA+ cells 11.3 ± 6.7%,
CD4+CD45RA− cells 88.7 ± 6.8%, CD8+CD45RA+ cells 37.0 ± 17.2%, CD8+
CD45RA− cells 63.0 ± 17.2%; Fig 2D). Frequencies of splenic CD4+ and
CD8+ T cells in CD3+ T cells are shown in Fig 2D (NSG, n = 7: CD4+ cells
72.8 ± 3.1%, CD8+ cells 21.5 ± 3.0%; hIL-7xhIL-15 KI NSG, n = 5: CD4+ cells
61.9 ± 4.7%, CD8+ cells 31.6 ± 3.5%. P = 0.068 in CD4+ cells and P = 0.052
in CD8+ cells by two-tailed t test; Fig 2D). Frequency of Foxp3+ cells in
CD4+ T cells was similar between NSG and hIL-7xhIL-15 KI NSG
humanizedmice (NSG, n = 7: 8.8 ± 1.5%; hIL-7xhIL-15 KI NSG, n = 5: 6.5 ±
2.4%. P = 0.41 by two-tailed t test). Although we found enhanced
human NK cells and T-cell development in hIL-7xhIL-15 KI NSG
humanized mice, TCRVα24+Vβ11+CD3+ NKT cells were not detected
(representative flow cytometry plots in Fig 2E). This suggests that
hIL-7 and hIL-15 play distinct roles in the development of human NK
and NKT cells.
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Table 1. Engraftment of human leukocytes in NSG mice expressing hIL-7 and/or hIL-15.
Mouse ID CB ID Strain Weeka
Spleen, % PB, %
hCD45+b CD56+ CD3+ CD19+ CD33+ hCD45+b CD56+ CD3+ CD19+ CD33+
IL7x15#1 CB#1 hIL-7xhIL-15 KI 15 46.6 35.3 11.4 19.2 15.3 15.0 60.4 6.5 2.4 6.1
IL7x15#2 CB#1 hIL-7xhIL-15 KI 18 35.8 38.6 1.3 11.1 10.4 30.5 68.5 1.3 11.1 10.4
IL7x15#3 CB#2 hIL-7xhIL-15 KI 10 98.1 13.0 0.1 78.8 3.1 93.6 38.5 0.3 42.2 7.8
IL7x15#4 CB#2 hIL-7xhIL-15 KI 16 92.7 3.8 23.5 57.8 5.7 95.9 19.2 37.4 15.4 10.1
IL7x15#5 CB#3 hIL-7xhIL-15 KI 13 76.0 18.7 0.2 67.1 3.5 22.3 70.6 0.1 11.7 9.4
IL7x15#6 CB#4 hIL-7xhIL-15 KI 19 77.7 22.1 2.5 49.0 4.1 30.4 37.7 2.5 26.7 4.9
IL7x15#7 CB#4 hIL-7xhIL-15 KI 22 66.8 26.0 26.8 26.5 3.6 18.8 38.3 33.1 21.0 1.4
IL7x15#8 CB#4 hIL-7xhIL-15 KI 23 64.4 16.2 10.1 16.2 6.6 15.7 6.0 18.2 24.3 3.1
IL7x15#9 CB#5 hIL-7xhIL-15 KI 13 80.6 36.6 1.7 40.8 8.2 49.2 47.2 1.2 19.3 20.0
IL7x15#10 CB#6 hIL-7xhIL-15 KI 19 65.9 52.9 1.0 17.3 14.5 30.8 64.9 0.6 6.9 8.3
IL7x15#11 CB#7 hIL-7xhIL-15 KI 16 97.0 1.2 74.6 15.4 3.4 98.7 9.8 69.2 1.2 1.0
IL7x15#12 CB#7 hIL-7xhIL-15 KI 17 92.3 2.6 72.5 17.6 2.6 85.8 14.3 67.6 3.6 1.8
IL7x15#13 CB#8 hIL-7xhIL-15 KI 13 51.1 21.7 0.9 60.0 11.5 4.8 37.6 0.7 13.3 22.6
IL7x15#14 CB#9 hIL-7xhIL-15 KI 20 28.8 56.0 2.5 11.5 9.2 11.6 70.2 1.4 7.6 10.5
IL7x15#15 CB#10 hIL-7xhIL-15 KI 11 78.7 9.4 0.4 76.1 5.1 77.1 25.2 0.3 34.7 27.9
IL7x15#16 CB#11 hIL-7xhIL-15 KI 15 58.7 72.8 1.1 12.9 6.7 7.4 68.8 0.0 8.5 15.3
IL7x15#17 CB#12 hIL-7xhIL-15 KI 15 74.1 54.1 0.8 27.8 8.1 20.1 55.4 0.9 20.8 2.0
IL7x15#18 CB#13 hIL-7xhIL-15 KI 8 68.9 25.6 0.0 54.1 7.8 7.7 24.6 0.0 29.1 33.0
IL7x15#19 CB#14 hIL-7xhIL-15 KI 16 23.9 87.5 0.5 7.6 1.5 2.2 82.8 0.8 5.5 3.1
IL7x15#20 CB#15 hIL-7xhIL-15 KI 9 56.9 31.3 0.0 32.3 22.5 35.9 60.0 0.1 8.2 18.2
IL7x15#21 CB#16 hIL-7xhIL-15 KI 11 46.5 61.5 1.2 24.1 3.6 31.2 70.7 1.2 12.4 4.9
IL7x15#22 CB#17 hIL-7xhIL-15 KI 10 90.4 8.6 0.4 72.5 8.6 75.6 29.8 0.8 35.6 28.3
IL7x15#23 CB#17 hIL-7xhIL-15 KI 11 77.3 7.7 0.5 77.3 10.1 61.7 13.8 0.8 49.2 27.5
IL7KI#1 CB#13 hIL-7 KI 18 99.5 0.4 1.5 11.5 83.9 97.2 1.1 4.4 4.6 85.4
IL7KI#2 CB#13 hIL-7 KI 19 87.9 5.0 10.7 36.6 37.9 83.3 11.7 20.0 23.4 27.8
IL7KI#3 CB#14 hIL-7 KI 21 90.5 3.1 10.3 25.9 57.1 59.9 4.5 18.4 40.9 25.6
IL7KI#4 CB#14 hIL-7 KI 19 93.7 1.9 10.4 49.4 34.5 98.4 1.9 63.4 14.1 15.0
IL7TG#5 CB#15 hIL-7 Tg 16 97.8 1.2 8.0 58.6 22.2 92.3 1.7 32.1 25.2 26.2
IL7TG#6 CB#16 hIL-7 Tg 12 81.0 0.6 2.5 73.9 8.5 93.1 0.7 2.2 73.9 14.4
IL7TG#7 CB#17 hIL-7 Tg 24 95.6 0.3 2.1 11.3 84.9 81.9 0.3 0.2 2.8 95.4
NSG#1 CB#1 NSG 20 79.8 0.3 48.6 40.1 1.6 43.6 0.2 91.1 5.0 0.7
NSG#2 CB#2 NSG 17 78.1 0.2 77.5 19.1 1.4 68.5 0.2 96.9 1.0 0.2
NSG#3 CB#2 NSG 18 85.9 0.6 14.8 74.5 3.9 37.8 0.6 50.8 28.9 11.4
NSG#4 CB#3 NSG 18 90.3 1.2 7.5 76.7 6.4 59.8 1.2 15.2 51.6 17.2
NSG#5 CB#3 NSG 19 92.4 1.2 20.5 72.4 3.5 81.5 2.5 44.0 44.3 3.6
NSG#6 CB#3 NSG 20 91.7 1.1 10.8 72.6 5.4 68.1 1.0 28.2 36.7 22.4
NSG#7 CB#5 NSG 18 71.6 0.9 52.4 47.9 1.2 37.4 0.8 74.5 20.5 1.7
NSG#8 CB#5 NSG 19 90.2 0.2 77.6 24.0 0.9 79.9 0.6 89.2 7.0 2.3
NSG#9 CB#7 NSG 17 98.8 0.1 64.8 30.9 1.2 97.9 0.6 83.3 10.6 0.3
NSG#10 CB#8 NSG 19 88.6 2.3 40.9 48.2 6.4 36.1 1.9 46.1 42.9 4.9
NSG#11 CB#8 NSG 19 88.5 0.7 35.3 58.1 4.8 39.4 0.3 46.6 48.7 2.3
NSG#12 CB#10 NSG 20 98.6 0.1 60.2 32.1 0.8 97.0 0.5 85.5 7.7 1.3
(Continued on following page)
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Maturation and location of human NK cells in hIL-7xhIL-15 KI NSG
humanized mice
After the development of human NK cells in the primary immune
organs (BM and thymus), they undergo maturation in peripheral
organs such as spleen (Freud et al, 2014; Bjorkstrom et al, 2016).
We analyzed frequencies of human NK cells and assessed the
degree of maturation in hIL7xhIL15 KI NSG humanized mice.
Among CD56+ cells, we found significantly higher percentages of
human CD56+CD94+CD16+ relatively mature NK cells in the spleen
and PB of the hIL-7xhIL-15 KI NSG humanized mice compared with
NSG humanized mice (NSG, n = 20: BM CD94+CD16+ cells 28.8 ± 4.7%,
spleen CD94+CD16+ cells 27.2 ± 2.8%; hIL-7xhIL-15 KI NSG, n = 16:
BM CD94+CD16+ cells 42.6 ± 4.4%, spleen CD94+CD16+ cells 73.6 ± 3.1%;
NSG, n = 17: PB CD94+CD16+ cells 40.7 ± 4.1%; hIL-7xhIL-15 KI NSG,
n = 13: PB CD94+CD16+ cells 83.8 ± 2.3%. P < 0.001 in spleen and PB
by two-tailed t test; Fig 3A and B absolute numbers of cells are
shown in Table S3). In line with phenotypical maturation, human
NK cells developing in hIL-7xhIL-15 NSG humanized mice showed
higher expression of perforin and granzyme B, CD56+ NK cell
subset (NSG, n = 13: perforin+ cells 25.1 ± 5.6%, granzyme B+ cells
17.8 ± 4.7%, perforin+ granzyme B+ cells 12.7 ± 3.9%; hIL-7xhIL-15 KI
NSG, n = 10: perforin+ cells 61.4 ± 4.3%, granzyme B+ cells 47.0 ±
4.3%, perforin+ granzyme B+ cells 39.5 ± 3.4%. P < 0.001 in perforin+
cells, perforin+ granzyme B+ cells, and granzyme B+ cells by two-tailed
t test; Fig 3C and D, absolute numbers of cells are shown in Table S3).
We next assessed functional capacity of human NK cells developing
in conventional NSG humanized mice and hIL-7xhIL-15 NSG hu-
manized mice using in vitro cytotoxicity assay. hIL-7xhIL-15 NSG
spleenNK cells exhibited cytotoxicity at a similar level comparedwith
human PB NK cells (NSG, n = 3: 5.7% ± 2.2%; hIL-7xhIL-15 KI NSG, n = 8:
12.4 ± 1.8%; human PB, n = 2: 8.1 ± 1.8%; Fig 3E).
When we analyzed PFA-fixed, paraffin-embedded thin sections
of the recipient spleens, we found cells that were specifically
stained with anti-hCD56 and NKp46 antibody. Whereas hCD3+ T cell
and hCD19+ B cells appeared to form lymphoid clusters, human NK
cells were distributed outside lymphoid clusters, consistent with
physiological distribution of human NK cells in human spleen
(Witte et al, 1990) (Figs 4 and S4). These findings indicate that hIL-7
and hIL-15 support multiorgan development and maturation of
human NK cells in humanized mice.
Maintenance of human NKT cells in hIL-7xhIL-15 KI NSG mice
Although TCRVα24+Vβ11+CD3+ NKT cells were not detected in the BM
and spleen of hIL-7xhIL-15 KI NSG humanized mice, we examined
whether human IL-7 and human IL-15 maintain human NKT cells for
longer term in the BM and lungs. We intravenously injected 2 × 106
cells, human NKT cells, or iPS-NKT cells into NSG mice or hIL-7xhIL-
15 KI NSGmice. In hIL-7xhIL-15 KI NSGmice, we detected NKT cells or
iPS-NKT cells in the BM and lungs at higher frequencies at 14 d
postinjection (NSG, n = 4: BM NKT cells 0.000%, lung NKT cells 0.001 ±
0.002%; hIL-7xhIL-15 n = 11 BM NKT cells 0.084 ± 0.025%, lung NKT
cells 0.079 ± 0.014%, P = 0.07 in BM and P < 0.01 in the lungs by two-
tailed t test; Fig S5). This finding indicates that hIL-7 and hIL-15 play
an important role for the survival of human NKT cells.
Gene expression signatures of human NK cells in hIL-7xhIL-15 KI
NSG mice
Furthermore, we examined gene expression profiles of human NK
cells in hIL-7xhIL-15 KI NSG humanizedmice by RNA sequencing (Fig 5).
We purified hCD45+CD56+CD3− splenic NK cells from hIL-7xhIL-15 KI
NSG and conventional NSG humanized mice. In comparison with
gene expression signatures of human NK cells in conventional NSG
humanized mice and human PBMC-derived NK cells (GSE64655)
(Hoek et al, 2015), expression of PRDM1, CCL4L1, CCL4, KIR2DS4,
KIR2DL1, KIR2DL3, KIR3DL1, and KIR2DP1 was up-regulated in human
NK cells from hIL-7xhIL-15 KI NSG humanized mice. In addition,
Table 1. Continued
Mouse ID CB ID Strain Weeka
Spleen, % PB, %
hCD45+b CD56+ CD3+ CD19+ CD33+ hCD45+b CD56+ CD3+ CD19+ CD33+
NSG#13 CB#10 NSG 20 93.9 0.8 56.7 38.7 3.2 79.8 2.3 78.8 7.2 5.6
NSG#14 CB#12 NSG 19 84.4 1.0 37.8 55.8 3.3 56.7 0.9 54.1 41.7 1.6
NSG#15 CB#12 NSG 21 85.1 0.7 40.4 53.1 2.7 49.9 0.7 56.0 34.7 3.8
NSG#16 CB#13 NSG 22 95.9 0.2 75.9 13.4 2.2 97.4 0.4 90.0 2.2 3.6
NSG#17 CB#13 NSG 23 78.5 1.8 61.8 27.1 3.9 28.5 4.3 64.8 18.9 3.5
NSG#18 CB#14 NSG 21 82.1 0.4 38.8 56.4 2.3 31.5 0.2 63.3 29.1 3.4
NSG#19 CB#18 NSG 17 93.7 0.7 55.3 38.9 1.5 62.0 1.0 75.8 18.5 1.8
NSG#20 CB#18 NSG 19 83.3 0.6 49.7 43.9 0.9 66.1 0.6 88.9 6.3 0.1
NSG#21 CB#19 NSG 20 99.7 0.3 83.0 13.4 1.4 99.0 0.5 90.9 4.9 1.5
NSG#22 CB#18 NSG 19 89.9 1.7 54.5 36.5 2.1 64.7 1.4 76.5 18.1 1.4
NSG#23 CB#18 NSG 19 93.6 0.5 16.0 79.6 1.0 81.7 0.5 20.2 76.7 0.2
NSG#24 CB#19 NSG 17 87.0 2.0 46.4 45.1 3.3 42.8 7.0 65.9 14.1 2.8
aNumber of weeks after CB transplantation when euthanized are shown.
bFrequencies of human CD45+ cells in total leukocytes including human and mouse CD45+ cells.
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cytotoxicity-related genes such as GZMA, GZMB, and PRF1 were up-
regulated. Similarity of NK cell–associated gene expression between
splenic human NK cells in hIL-7xhIL-15 KI NSG humanized mice and
human PBMC-derived NK cells suggest that human IL-7 and IL-15 in
the splenic microenvironment enhances human NK cell maturation.
In contrast, expression of AHR and IL-7R were down-regulated in NK
cells of hIL-7xhIL-15 KI NSG humanized mice and human PBMC
compared with those of conventional NSG humanized mice. Among
the differentially expressed genes, we analyzed the expression of
KIR at the protein level by flow cytometry. Consistent with the
transcriptome analysis, expression of KIRs was higher in NK cells
developed in hIL-7xhIL-15 KI NSG humanized mice compared with
those in conventional NSG humanized mice (3.6 ± 0.8% in NSG, n = 5;
12.3 ± 0.4% in hIL-7xhIL-15, P < 0.001 by two-tailed t test; Fig S6).
Discussion
NK cells were first reported in 1975 (Herberman et al, 1975; Kiessling
et al, 1975; Sendo et al, 1975). NK cells exert potent cytotoxic function
Figure 1. Increased reconstitution of human NK cells in NSG hIL-7xhIL-15 humanized mice.
(A, B) Representative flow cytometry plots of (A) the BMand (B) the thymus of conventional NSG and hIL-7xhIL-15 KI NSGhumanizedmice (IL7xIL15). (C) Increased frequencies of
CD56+ NK cells are detected in the BM, spleen, PB, and thymus of NSG hIL-7xhIL-15 KI humanized mice (BM, spleen, and PB: NSG n = 21, IL7TG n = 3, IL7KI n = 4, IL7xIL15 n = 17,
thymus: NSG n = 18, IL7xIL15 n = 13). (D) Quantitative gene expression of hIL-15 by Gra1+Mac1+ mousemyeloid cells or hCD45+CD33+ humanmyeloid cells purified from BM of NSG
(left two columns) or hIL-7xhIL-15 KI NSG (right two columns) humanizedmice are presented relative to β-actin (NSG n = 3 and IL7xIL15 n = 3). (E) Representative flow cytometry
plots of the BM, liver, and PB of hIL-7xhIL-15 KI NSG humanizedmice showing CXCR6 expression among human NK cells. (F) Frequencies of CXCR6+CD56+ tissue-resident NK cells
in the BM, liver, and PB of NSG hIL-7xhIL-15 KI humanized mice (BM n = 8, Liver n = 5, PB n = 4). Error bars represent mean ± SEM. *P < 0.001, by two-tailed t test.
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against virus-infected cells and MHC-deficient tumor cells. Dif-
ferent from T cells, NK cells are activated when they do not receive
inhibitory signals through killer cell immunoglobulin-like receptor
(KIR)–MHC interaction. This mechanism leads to rapid NK cell–
mediated immune reaction and induction of apoptosis in MHC-
escaping malignant cells (Anfossi et al, 2006). Like other immune
Figure 2. Development of human T-cell subsets in NSG hL-7xhIL-15 humanized mice.
(A) Representative flow cytometry plots of thymic T-cell subset of conventional NSG and hIL-7xhIL-15 KI NSG (IL7xIL15) humanized mice. (B) Frequencies of thymic CD4+ T
cells, CD8+ T cells, and CD4+CD8+ T cells in NSG (n = 17) and hIL-7xhIL-15 KI NSG humanizedmice (n = 12). (C) Representative flow cytometry plots of splenic T-cell subsets in a
hIL-7xhIL-15 KI NSG humanizedmouse. (D) Frequencies of splenic CD4+ T cells, CD8+ T cells, CD45RA−memory CD4+ T cells, and CD45RA−memory CD8+ T cells in conventional
NSG (n = 7) and hIL-7xhIL-15 KI NSG (n = 5) humanized mice. (E) Representative flow cytometry plots showing a lack of TCR Vα24+Vβ11+ NKT cells in the BM, spleen, and
thymus of a hIL-7xhIL-15 KI NSG humanized mouse. Error bars represent mean ± SEM (*P < 0.001, by two-tailed t test).
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cells, development, maturation, and function of NK cells have been
extensively studied using genetically engineered mouse models
(Kennedy et al, 2000; Fehniger et al, 2001). Although mouse and
human NK cell development share some aspects in their biological
function and transcriptome, there are differences between human
and mouse NK cells such as the use of Ly49 receptors by mouse NK
cells versus the use of KIR by human NK cells for the recognition of
MHC (Colucci et al, 2002). In the present study, we aimed to develop
an in vivo model supporting human NK cell maturation and to
assess roles of cytokine receptor signaling in human NK cell de-
velopment. In particular, we aimed to address the following two
questions: (1) How do human NK cells develop and distribute in
primary and secondary lymphoid organs? (2) How do human NK
cells become functionally mature in the microenvironment? To
answer these questions, we created NSG mice expressing hIL-7
alone and those expressing both hIL-7 and hIL-15. Unlike NSG mice
expressing hIL-7 alone, concurrent expression of hIL-15 resulted in
enhanced in vivo human NK development in multiple organs, but
not in T cells or NKT cells. Histologically, whereas human T cells and
human B cells existed mainly near white pulp-like structures, most
human NK cells were located outside the white pulp-like area,
consistent with human splenic architecture (Witte et al, 1990). The
Figure 3. NK cells show a mature phenotype and cytotoxicity in NSG hL-7xhIL-15 humanized mice.
(A) Representative flow cytometry plots of splenic NK cell maturation in conventional NSG and hIL-7xhIL-15 KI NSG humanized mice (IL7xIL15). (B) Increased frequencies of
CD56+CD94+CD16+ mature NK cells are detected in the BM, spleen, and PB of hIL-7xhIL-15 KI NSG humanized mice (NSG: BM and spleen n = 20, PB n = 17; IL7xIL15: BM and
spleen n = 16, PB n = 13). (C) Representative flow cytometry plots of cytoplasmic expression of granzyme B and perforin in the spleen of NSG and hIL-7xhIL-15 KI NSG
humanized mice. (D) Frequencies of granzyme B– and perforin-positive cells among splenic CD56+ NK cells in NSG (n = 13) and hIL-7xhIL-15 KI NSG (n = 10) humanized mice.
(E) In vitro cytotoxicity of human NK cells isolated from spleen of conventional NSG, hIL-7xhIL-15 KI NSG humanized mouse spleen (circles) and BM (triangles), and from
normal human PB samples (squares) against K562 are shown (NSG n = 3; IL7xIL15 n = 7; normal human PB n = 2). Error bars represent mean ± SEM. *P < 0.05, **P < 0.001, by
two-tailed t test.
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BM is considered as a primary organ for NK cell development and
maturation (Huntington et al, 2007). Although emerging evidence
has suggested that thymus is also important for NK cell develop-
ment, it has yet to be understood whether thymus provides
essential environmental factors for mouse and human NK cells
(Freud et al, 2014; Bjorkstrom et al, 2016). In our xenograft, we found
CD56+ NK cells in both BM and thymus. Thymic NK cells were re-
ported to express IL-7R in mice and human (Vosshenrich et al,
2006). Consistent with the report, we found IL-7R+CD56+NK cells in
the thymus of hIL-7xhIL-15 KI NSG humanized mice (representative
flow cytometry plots were shown in Fig S7). This result may suggest
that hIL-7 signaling is important for human NK cell development
particularly in thymus.
To date, the frequency of CD56+CD16+ mature human NK cells in
xenotransplantation models have not fully reflected physiological
levels. Our report is consistent with previous publications using in
vivo administration of hIL-15 or hIL-15-hIL-15Rα complex to hu-
manized mice (Huntington et al, 2009; Strowig et al, 2010) and
more recently, using hIL-15 expressing BALBc/Rag2KO/Il2rgKO
mice assessing differentiation and function of human NK cells
in vivo (Herndler-Brandstetter et al, 2017). The new NSG mouse
model described in the present work further supports critical
roles of IL-15 in human NK cell development. In our new strain, we
found CXCR6+CD56+ tissue-resident NK cells in the BM and liver.
Because tissue-resident NK cells and circulating NK cells are
different in cytotoxicity or cytokine production (Melsen et al, 2018),
hIL-7xhIL-15 KI NSG humanized mice could be useful for studying
the two distinct subsets of human NK cells. In addition to flow
cytometric analysis of engrafted human NK cells, we performed
transcriptome analysis by RNA sequencing. We found that the
gene expression signature of human NK cells in hIL-7xhIL-15 KI
NSG humanized mice was more similar to those in human PB as
compared with human NK cells in conventional NSG humanized
mice. It would be notable that maturation or cytotoxic markers
such as KIRs, chemokine ligands (CCL4L1 and CCL4), cytotoxicity-
related genes (GZMA and GZMB), as well as PRDM1 were up-
regulated in the NK cells in hIL-7xhIL-15 KI NSG humanized
mice because all these genes were known as NK-specific func-
tional molecules (Fehniger et al, 1999; Parham, 2005; Yawata et al,
2006; Smith et al, 2010), and that the new humanized mice could
be a better in vivo model for assessing interaction between NK
cells and diseased cells.
We also assessed potential development and survival of human
NKT cells in the NSG mice expressing hIL-7 and hIL-15. In the mice
engrafted with human CB HSCs, we did not see differentiation of
human NKT cells in organs such as the BM, spleen, and lungs,
suggesting that these two cytokines are not sufficient to support
human NKT cell development. On the other hand, with in vivo
transfer of human NKT cells into hIL-7xhIL-15 KI NSG mice, the
injected human NKT cells were detected at higher frequencies in
multiple organs as compared with NSG mice. Because NKT cells are
known to activate NK cells in vivo, the model would be useful to
analyze activation of human NK cells with intravenous injection of
human NKT cells (Carnaud et al, 1999; Fujii et al, 2010; Yamada et al,
2016).
Together, expression of hIL-7 and hIL-15 in the NSG humanized
mice resulted in efficient development of human NK cells in
multiple organs in the presence of multiple human immune
subsets, and the human NK cells undergo physiological matu-
ration process and exhibit cytotoxicity. The new humanized
mousemodel with hIL-7 and hIL-15 expression could be used as a
valuable tool for examining in vivo biology of human NK cells and
for in vivo testing of NK cell–mediated cytotoxicity against
cancer.
Materials and Methods
Human samples
Human CB cells were obtained from Tokai Cord Blood Bank and
Chubu Cord Blood Bank under written informed consent. All ex-
periments were authorized by the institutional review boards at
RIKEN.
Mice
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice were raised from a
breeding colony maintained at RIKEN. To generate human IL-7
transgenic mice (NSG.Cg-C57BL/6-Tg(Hu-IL7)1Rk) (hIL-7 TG), the
Figure 4. Distribution of splenic T cells, B cells, and
NK cells in NSG hL-7xhIL-15 humanized mice.
Thin sections of a hIL-7xhIL-15 NSG recipient spleen
stained with anti-hCD56, anti-CD3 and anti-CD19
antibodies. Low and high magnification images are
shown. hCD3+ T cell and hCD19+ B cells were found
within lymphoid clusters, whereas CD56+ NK cells are
located outside the clusters. Scale bars: low
magnification, 50 μm; high magnification, 20 μm.
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pBACe3.6 vector containing the human IL-7 genomic region (Fig S8A;
BAC clone RPCl11.C-19N15 [Thermo Fisher scientific]) was micro-
injected into the pronucleus of fertilized C57BL/6J (B6/J) mouse
embryos. To generate human IL-7 knockin mice (NSG.CG-STOCK-
IL7tm1.1(IL7)Rk) (hIL-7 KI mice) or human IL-15 knockin mice (NSG.CG-
STOCK-IL15tm1.1(IL15)Rk) (hIL-15 KI mice), B6/J × 129/Sv hybrid ES cells
were transfected with targeting vector containing human IL-7 or
human IL-15 cDNA by electroporation and cultured for 7–10 d to
select homologous recombinants. Then, correctly targeted ES cell
clones were aggregated with BDF2 morula to generate chimeric
mice. Male chimeras were mated with B6/J females, and hetero-
zygous offsprings were further mated with B6; SJL-Tg (ACTFLPe)
9205Dym/J mice to remove the PGK-Neo cassette (Fig S8A). hIL-7 TG
mice, hIL-7 KI mice, and hIL-15 KI mice were backcrossed more than
five generations onto the NSGmice. Backcrossing was performed by
means of natural mating, in vitro fertilization, or round spermatid
injection. Backcrossed mice at each generation were selected using
a marker-assisted selection protocol for further backcrossing.
Human IL-7 and human IL-15 double knockin NSGmice (hIL-7xhIL-15
KI NSG) were generated by crossing hIL-7 KI NSG mice and hIL-15 KI
NSG mice. B6/J and BDF1 mice were purchased from CLEA Japan. B6;
SJL-Tg (ACTFLPe)9205Dym/J mice were purchased from the Jackson
Laboratory.
All mice were bred and maintained under specific pathogen free
conditions at the animal facility of RIKEN Integrative Medical Sci-
ences. All animal experiments were performed in accordance with
Figure 5. Gene expression signature of NK cells in NSG hL-7xhIL-15 humanized mice.
RNA sequencing was performed using RNA extracted from hCD56+ splenic NK cells of conventional NSG (NSG, n = 2) and hIL-7xhIL-15 KI NSG (hIL7xhIL-15 KI NSG, n = 6)
humanized mice. (A) Differentially expressing genes are shown. Gene expression profiles of human NK cells of humanized mice were compared with those from NK cells
recovered from human PBMCs. (B) Expression of genes related to cytokine and cytotoxicity are shown.
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guidelines and approved by the Institutional Animal Care and Use
Committee of RIKEN.
Genotyping of NSG mice
hIL-7 TG mice, hIL-7 KI mice, and hIL-15 KI mice were genotyped by
PCR (Bio-Rad, Takara Bio, or BM Equipment). Primer information
used for this genotyping is shown in Fig S8B. The microsatellite
markers used for marker-assisted selection protocol were selected
based on sequence length polymorphisms between B6 mice and
NOD mice (according to Mouse Microsatellite Date Base of Japan
[MMDBJ]; https://shigen.nig.ac.jp/mouse/mmdbj/top.jsp, Table S5).
All primers were purchased from Life Technologies Japan.
Transplantation
Antihuman CD34 immune-magnetic beads (130-046-703; Miltenyi
Biotec) were used to enrich human CD34+ cells from CB samples.
Enriched human CD34+ cells were sorted for 7-AAD−Lin−hCD45+CD34+
CD38−CD45RA− or 7-AAD−Lin−hCD45+CD34+CD38−CD90+CD45RA− using
FACSAria or FACSAria III (BD Biosciences). NSG, hIL-7 Tg NSG, hIL-7 KI
NSG, and hIL-7xhIL-15 KI NSG newborn mice received 150 cGy total
body irradiation using a 137Cs-source irradiator, followed by in-
travenous injection of 2.5 × 103 to 2.6 × 104 sorted HSCs. Recipient PB
samples were evaluated for human hematopoietic engraftment
every 4 wk starting at 5–6 wk after transplantation. Recipients with
confirmed human hematopoietic engraftment at 10–24 wk after
transplantation were euthanized and analyzed.
Flow cytometric analysis
Cells obtained from PB and various organs were stained with mAbs
and analyzed using FACSAria, FACSAria III, or FACSCanto II (BD
Biosciences). The following mAbs were used for flow cytometry:
anti-hCD3-BV421 (UCHT1), -allophycocyanin (APC) (HIT3a), and
-BV786 (SK7), anti-hCD4-phycoerhthrin (PE)-Cy7 (SK3), anti-hCD8-
APC-Cy7 (SK1), anti-hCD10-BV421 (HI10a), anti-hCD16-PE-Cy7 (3G8),
and Pacific blue (3G8), anti-hCD19-PE-Cy7 (SJ25C1) and -BV786
(SJ25C1), anti-hCD20-APC (L27), anti-hCD33-PE (WM53), anti-hCD34-
PE-Cy7 (8G12), anti-hCD38-APC (HB7), anti-hCD45-APC (HI30), -BV510
(HI30), and -APC-H7 (2D1), anti-hCD45RA-FITC (HI100), anti-hCD56-
FITC (NCAM16.2), -BV421 (NCAM16.2), and -BV711 (NCAM16.2), anti-
hCD90-FITC (5E10), anti-hIgD-PE (IA6-2), anti-hIgM-FITC (G20-127),
anti-mCD45-APC-Cy7 (30-F11) and -BV510 (30-F11), anti-mCD11b-BV421
(Mac1) (M1/70), and Ly-6G/6C-FITC (Gra1) (RB6-8C5) (all from
BD Biosciences), anti-hTCR-Vα24-PE (C15), anti-hTCR-Vβ11-APC
(C21), anti-hCD127 (IL-7Ra) (R34.34) and anti-hCD158a,h (KIR2DL1/
2DS1) (EB6B) (all from Beckman Coulter), anti-hCD94-PE (HP-3D9;
eBioscience), and anti-hCD186-APC (CXCR6) (K041E5; BioLegend).
For analysis of regulatory T cells, cells stained withmAbs for surface
antigens were fixed and permeabilized using FoxP3/Transcription
Factor Staining Buffer Set (eBioscience). Permeabilized cells were
stained with anti-hFoxp3-APC (clone PCH101; eBioscience) and
analyzed using FACSCanto II (BD Biosciences). To analyze the ex-
pression of intracellular granzyme B and perforin, cells stained with
mAbs for surface antigens were fixed and permeabilized using BD
Cytofix/Cytoperm Kit (BD Biosciences). Permeabilized cells were
stained with anti-human granzyme B-FITC (GB11; BD Biosciences)
and anti-human perforin-PE (δG9; BD Biosciences) and analyzed
using FACSCanto II (BD Biosciences).
Measurement of plasma cytokine levels
To measure concentrations of cytokines in recipient plasma
samples, PB samples were obtained from NSG, hIL-7 Tg NSG, hIL-7 KI
NSG, and hIL-7xhIL-15 KI NSGmice using heparinized capillary tubes
(Drummond Scientific Company). Plasma human IL-7 concentration
was measured by ELISA (R&D Systems). Plasma human IL-15 con-
centration was measured by Bio-Plex Systems (Bio-Rad).
Cytotoxicity analysis
Human NK cells from recipient mice and human PBMCs were enriched
using NK cell isolation kit (Miltenyi Biotec). Cytotoxicity of NK cells
against K562 cells were measured using LDH cytotoxicity detection kit
(MK401, TaKaRa) (Korzeniewski & Callewaert, 1983; Fernandez et al, 1986;
Bae & Lee, 2014). In short, 2–5 × 104 human NK cells were cultured with
K562 at a ratio of 10:1 for 4 h followed by measurement of LDH in the
culture supernatant by ELISA at an absorbance of 490 nm and cyto-
toxicity was calculated as follows: cytotoxicity (%) = [(absorbance of NK
and K562 cell co-culture) − (absorbance of NK cells alone) − (absor-
bance of K562 alone) + (absorbance ofmediumalone)]/[(absorbance of
K562 in 10% Triton X) − (absorbance of K562 alone)] ×100.
Immunohistochemistry
Tissues were fixed with 4% paraformaldehyde, dehydrated, em-
bedded in paraffin, and cut into 3-μm sections. Following de-
paraffinization and rehydration, antigen retrieval was performed
using 0.1% calcium chloride solution (for CD56 and NCR1 [Nkp46]
labeling) or Retrievagen B solution (for CD3 or CD19 labeling) (pH 9.5;
BD Biosciences). Antigen retrieval was performed for 20 min at 90°C
for CD56 and Nkp46 labeling and at 94°C for CD3 and CD19 labeling
according to the manufacturer’s protocols. Endogenous peroxidase
activity and nonspecific binding were blocked with hydrogen
peroxide solution and 2.5% normal horse serum, respectively.
Primary antibodies used in the study were mouse antihuman CD56
(MOC-31; Abcam), rabbit antihuman Nkp46 (ab199128; Abcam),
mouse antihuman CD3 (PS1; Abcam), and rabbit antihuman CD19
(EPR5906; Abcam). ImmPRESS MP-7500 was used as the secondary
antibody (VECTOR). 3,39-diaminobenzidine (DAB; SK-4100, VECTOR)
and hematoxylin were used as the chromogen and counterstain,
respectively. After mounting with cover glass, images were obtained
using Axiovert 200 (Carl Zeiss).
NKT cell injection
Human NKT cells and human iPS-NKT cells were prepared using a
previously established method (Yamada et al, 2017). 2.0 × 106 NKT
cells were intravenously injected into NSG mice and hIL-7xhIL-15 KI
NSG mice. At 14 d postinjection, the recipients were euthanized and
analyzed for the presence of human NKT cells in the BM and lungs.
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RNA extraction and qPCR
BM cells of NSG and hIL7xhIL-15 KI NSG humanized mice were la-
beled with anti-mGra1-FITC, anti-hCD33-PE, anti-mCD45-APC-Cy7,
anti-Mac1-BV421, and anti-hCD45-BV510 to purify Mac1+Gra1+ mouse
myeloid cells and hCD45+CD33+ humanmyeloid cells using FACSAria
III (BD Biosciences). Total RNA was extracted using Trizol reagent
(Invitrogen). Total RNA was quantified using a fluorimetric Ribo-
Green assay, and RNA quality was assessed using Bioanalyzer
(Agilent Technologies). Extracted RNA was converted into cDNA
using Superscript III reverse transcriptase (Invitrogen). Real-time
PCR reactions were performed using Platinum Quantitative PCR
SuperMix-UDG (Invitrogen) on a LightCycler 480 real-time PCR
system (Roche) using the following primers:
IL-15-Forward 59-ACAGAAGCCAACTGGGTGAA-39;
IL-15-Reverse 59-TCCAAGAGAAAGCACTTCATTGC-39;
IL-15-Probe 59-(6FAM)CTTTGCAACTGGGGTGAACATCACTTTCCG (TAM)-39.
Relative expression levels were calculated for each gene using
ACTB for normalization.
RNA sequencing analysis
Total RNA extracted from splenic CD56+ NK cells in NSG recipient, and
hIL-7xhIL-15 KI NSG recipient was prepared for RNA sequencing using
NEBNext Ultra RNA Library Prep kit for Illumina (catalog number
E7530; New England Biolabs). Final library size distribution was
validated using Bioanalyzer and quantified using quantitative PCR.
The DNA libraries were hybridized to a flow cell, amplified on the
Illumina cBot, and subsequently run on theHiseq 2500 (Illumina, on a
50-base single-end read mode). Raw data are deposited at the
National Bioscience Database Center (accession number: hum0171).
The sequence reads were mapped to the human genome (NCBI
version 19) using TopHat2 version 2.0.8 and botwie2 version 2.1.0 with
default parameters, and gene annotation was provided by NCBI
RefSeq. The transcript abundances were estimated using Cufflinks
(version 2.1.1). Cufflinks was run with the same reference annotation
with TopHat2 to generate FPKM (fragments per kilobase per million
mapped reads) values for known gene models.
Quantification and statistical analysis
Quantification and statistical analysis were performed using excel.
The numerical data are presented as means ± SEM. The differences
were determined by two-tailed t tests, and P value < 0.05 was
considered statistically significant.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201800195.
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